We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Lipids and Lipid Disorders
 41-60 of 406 Articles
Original Investigation |  FREE
Stephen F. Derose, MD, MS; Kelley Green, RN, PhD; Elizabeth Marrett, MPH; et al.
JAMA Intern Med. 2013;173(1):38-43. doi:10.1001/2013.jamainternmed.717.
Includes: CME, Supplemental Content

Invited Commentary | 
Amit V. Khera, MD; Samia Mora, MD, MHS
Arch Intern Med. 2012;172(22):1710-1711. doi:10.1001/2013.jamainternmed.263.

Research Letters |  FREE
David Faeh, MD, MPH; Julia Braun, MSc; Matthias Bopp, PhD, MPH
Arch Intern Med. 2012;172(22):1766-1768. doi:10.1001/2013.jamainternmed.327.
Includes: Supplemental Content

Editorial | 
J. Michael Gaziano, MD, MPH
Arch Intern Med. 2012;172(22):1705-1706. doi:10.1001/jamainternmed.2013.1771.

Original Investigation |  FREE
Davinder Sidhu, MD, LLB; Christopher Naugler, MSc, MD, CCFP, FCFP, FRCPC
Arch Intern Med. 2012;172(22):1707-1710. doi:10.1001/archinternmed.2012.3708.

Invited Commentary | 
Fiona Taylor, PhD, HonMFPH; Shah Ebrahim, DM, FRCP
Arch Intern Med. 2012;172(12):919-920. doi:10.1001/archinternmed.2012.2434.

Editor's Correspondence | 
Niki Katsiki, MSc, PhD, MD, FRSPH; Maciej Banach, MD, PhD, FAHA, FESC, FASA, FRSPH
Arch Intern Med. 2012;172(11):895-896. doi:10.1001/archinternmed.2012.1240.

Editor's Correspondence | 
Harold Zeliger, PhD
Arch Intern Med. 2012;172(11):896-897. doi:10.1001/archinternmed.2012.1243.

Editor's Correspondence | 
Annie L. Culver, BPharm; Ira S. Ockene, MD; Yunsheng Ma, MD, PhD
Arch Intern Med. 2012;172(11):896-897. doi:10.1001/archinternmed.2012.1613.

Invited Commentary | 
Frank B. Hu, MD, PhD; JoAnn E. Manson, MD, DrPH
Arch Intern Med. 2012;172(9):694-696. doi:10.1001/archinternmed.2012.463.

Review Article |  FREE
Sang Mi Kwak, MD; Seung-Kwon Myung, MD; Young Jae Lee, MD, MS; et al.
Arch Intern Med. 2012;172(9):686-694. doi:10.1001/archinternmed.2012.262.

Special Article | 
Nicholas S. Downing, AB; Joseph S. Ross, MD, MHS; Cynthia A. Jackevicius, PharmD, MSc; et al.
Arch Intern Med. 2012;172(9):724-730. doi:10.1001/archinternmed.2012.187.

Special Article | 
Vinay Prasad, MD; Andrae Vandross, MD
Arch Intern Med. 2012;172(8):656-659. doi:10.1001/archinternmed.2012.812.

Original Investigation |  FREE
Valentina A. Andreeva, PhD; Mathilde Touvier, PhD; Emmanuelle Kesse-Guyot, PhD; et al.
Arch Intern Med. 2012;172(7):540-547. doi:10.1001/archinternmed.2011.1450.

Editor's Correspondence | 
Andrew Hayen, MBiostat, PhD; Katy Bell, MBBCh, PhD; Paul Glasziou, FRACGP, PhD; et al.
Arch Intern Med. 2012;172(4):374-375. doi:10.1001/archinternmed.2011.807.

Editor's Correspondence | 
Fritha Morrison, MPH; Maria Shubina, ScD; Alexander Turchin, MD, MS
Arch Intern Med. 2012;172(4):374-375. doi:10.1001/archinternmed.2011.1414.

Clinical Observation | 
Sara Simonelli, PhD; Elisabetta Gianazza, PhD; Giuliana Mombelli, MD; et al.
Arch Intern Med. 2012;172(2):179-181. doi:10.1001/archinternmed.2011.661.

Original Investigation |  FREE
Scott R. Garrison, MD; Colin R. Dormuth, ScD; Richard L. Morrow, MA; et al.
Arch Intern Med. 2012;172(2):120-126. doi:10.1001/archinternmed.2011.1029.
Includes: Supplemental Content

Original Investigation |  FREE
Annie L. Culver, BPharm; Ira S. Ockene, MD; Raji Balasubramanian, ScD; et al.
Arch Intern Med. 2012;172(2):144-152. doi:10.1001/archinternmed.2011.625.

Original Investigation |  FREE
Deborah A. Levine, MD, MPH; Ellen M. Funkhouser, DrPH; Thomas K. Houston, MD, MPH; et al.
Arch Intern Med. 2011;171(21):1910-1917. doi:10.1001/archinternmed.2011.498.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
From The Medical Letter on Drugs and Therapeutics  | 
Alirocumab (Praluent) to Lower LDL-Cholesterol

Clinical Trials Update  | 
Antisense Inhibitor Lowers High Triglycerides
Anita Slomski, MA
Original Investigation  | 
Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease A Randomized Clinical Trial
Clara K. Chow, MBBS, PhD; Julie Redfern, PhD; Graham S. Hillis, MBChB, PhD; et al.
News From the Food and Drug Administration  | 
New Drug to Lower LDL Cholesterol
Rebecca Voelker, MSJ